We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 09, 2022

Effect of Metformin and Statins on the Outcomes in Men With mCRPC

European Journal of Cancer


Additional Info

Disclosure statements are available on the authors' profiles:

European Journal of Cancer
Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302
Eur. J. Cancer 2022 May 11;[EPub Ahead of Print], BE Wilson, AJ Armstrong, J de Bono, CN Sternberg, CJ Ryan, HI Scher, MR Smith, D Rathkopf, CJ Logothetis, KN Chi, RJ Jones, F Saad, P De Porre, N Tran, P Hu, S Gillessen, J Carles, K Fizazi, AM Joshua

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading